Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QYU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,922
Award facts
- Contract value 100% obligated
- $2,922.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,922.21 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. The contract, awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive range of medications, vaccines, and medical supplies through its DLA contracts. The company's federal procurement portfolio demonstrates consistent competitively awarded, non-set-aside contracts ranging from small transactions to substantial orders, showcasing its capability to meet diverse military healthcare needs. The broader DLA Troop Support Medical contract enables AmerisourceBergen to serve multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key supplier within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F3QYU?
SPE2DR26F3QYU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F3QYU worth?
The government has obligated $2,922 on SPE2DR26F3QYU.
Is contract SPE2DR26F3QYU an order under another contract?
Yes. SPE2DR26F3QYU is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QYU competed?
The extent of competition for SPE2DR26F3QYU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award